Genetics of the bone response to bisphosphonate treatments

about

Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics.The estrogen receptor 1 gene affects bone mineral density and osteoporosis treatment efficiency in Slovak postmenopausal women

P2860

Q35112085-BBB853C1-1791-45F8-9973-20BAC8B6F57F Q58707068-FA9E7179-8B8D-4AAC-84EB-40F335F3B315

P2860

Genetics of the bone response to bisphosphonate treatments

Item

http://www.wikidata.org/entity/Q37430395

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetics of the bone response to bisphosphonate treatments

@en

Genetics of the bone response to bisphosphonate treatments.

@nl

type

Item

label

Genetics of the bone response to bisphosphonate treatments

@en

Genetics of the bone response to bisphosphonate treatments.

@nl

prefLabel

Genetics of the bone response to bisphosphonate treatments

@en

Genetics of the bone response to bisphosphonate treatments.

@nl

P1476

Genetics of the bone response to bisphosphonate treatments

@en

P2093

Francesco Massart

http://www.w3.org/2001/XMLSchema#string

Maria Luisa Brandi

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene

Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci

A sequence-based map of the nine genes of the human interleukin-1 cluster

Biologic basis for interleukin-1 in disease

Collagen Ialpha1 Sp1 polymorphism, bone mass, and bone turnover in healthy French premenopausal women: the OFELY study.

Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice.

Treatment of bone diseases with bisphosphonates, excluding osteoporosis.

The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.

P304

50-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22461098

http://www.w3.org/2001/XMLSchema#string

P932

2781213

http://www.w3.org/2001/XMLSchema#string

Genetics of the bone response to bisphosphonate treatments

about

P2860

P2860

Genetics of the bone response to bisphosphonate treatments

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932